Cited In for PMID: 22043968

Year	Number of Results
2011	3
2012	17
2013	21
2014	19
2015	15
2016	14
2017	9
2018	16
2019	10
2020	5
2021	5
2022	11
2023	4
2024	5

1

ADHD drugs and serious cardiovascular events in children and young adults.

Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC, Murray KT, Quinn VP, Stein CM, Callahan ST, Fireman BH, Fish FA, Kirshner HS, O'Duffy A, Connell FA, Ray WA. Cooper WO, et al. N Engl J Med. 2011 Nov 17;365(20):1896-904. doi: 10.1056/NEJMoa1110212. Epub 2011 Nov 1. N Engl J Med. 2011. PMID: 22043968 Free PMC article.

2

Methylphenidate and Short-Term Cardiovascular Risk.

Garcia-Argibay M, Bürkner PC, Lichtenstein P, Zhang L, D'Onofrio BM, Andell P, Chang Z, Cortese S, Larsson H. Garcia-Argibay M, et al. JAMA Netw Open. 2024 Mar 4;7(3):e241349. doi: 10.1001/jamanetworkopen.2024.1349. JAMA Netw Open. 2024. PMID: 38446477 Free PMC article.

3

Antipsychotic Medications and Mortality in Children and Young Adults.

Ray WA, Fuchs DC, Olfson M, Patrick SW, Stein CM, Murray KT, Daugherty J, Cooper WO. Ray WA, et al. JAMA Psychiatry. 2024 Mar 1;81(3):260-269. doi: 10.1001/jamapsychiatry.2023.4573. JAMA Psychiatry. 2024. PMID: 38019523

4

Attention-Deficit/Hyperactivity Disorder Medications and Long-Term Risk of Cardiovascular Diseases.

Zhang L, Li L, Andell P, Garcia-Argibay M, Quinn PD, D'Onofrio BM, Brikell I, Kuja-Halkola R, Lichtenstein P, Johnell K, Larsson H, Chang Z. Zhang L, et al. JAMA Psychiatry. 2024 Feb 1;81(2):178-187. doi: 10.1001/jamapsychiatry.2023.4294. JAMA Psychiatry. 2024. PMID: 37991787 Free PMC article.

5

An overview on neurobiology and therapeutics of attention-deficit/hyperactivity disorder.

da Silva BS, Grevet EH, Silva LCF, Ramos JKN, Rovaris DL, Bau CHD. da Silva BS, et al. Discov Ment Health. 2023 Jan 5;3(1):2. doi: 10.1007/s44192-022-00030-1. Discov Ment Health. 2023. PMID: 37861876 Free PMC article. Review.

6

The Impact of Stimulant Medications on Blood Pressure and Body Mass Index in Children with Attention Deficit Hyperactivity Disorder.

Suess M, Chrenka EA, Kharbanda EO, Asche S, O'Connor PJ, Ekstrom H, Benziger CP. Suess M, et al. Acad Pediatr. 2024 Apr;24(3):424-432. doi: 10.1016/j.acap.2023.08.018. Epub 2023 Aug 29. Acad Pediatr. 2024. PMID: 37652161 Free PMC article.

7

Clinical practice guidelines for attention-deficit/hyperactivity disorder: recent updates.

Eom TH, Kim YH. Eom TH, et al. Clin Exp Pediatr. 2024 Jan;67(1):26-34. doi: 10.3345/cep.2021.01466. Epub 2023 Jun 14. Clin Exp Pediatr. 2024. PMID: 37321571 Free PMC article.

8

Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Storebø OJ, Storm MRO, Pereira Ribeiro J, Skoog M, Groth C, Callesen HE, Schaug JP, Darling Rasmussen P, Huus CL, Zwi M, Kirubakaran R, Simonsen E, Gluud C. Storebø OJ, et al. Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD009885. doi: 10.1002/14651858.CD009885.pub3. Cochrane Database Syst Rev. 2023. PMID: 36971690 Free PMC article. Review.

9

New-Onset Accelerated Idioventricular Rhythm During Dental Rehabilitation.

Rizner JD, Bartlett HL, Shaw RE. Rizner JD, et al. Anesth Prog. 2022 Dec 1;69(4):32-36. doi: 10.2344/anpr-69-02-13. Anesth Prog. 2022. PMID: 36534779 Free PMC article.

10

Risk of Cardiovascular Diseases Associated With Medications Used in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-analysis.

Zhang L, Yao H, Li L, Du Rietz E, Andell P, Garcia-Argibay M, D'Onofrio BM, Cortese S, Larsson H, Chang Z. Zhang L, et al. JAMA Netw Open. 2022 Nov 1;5(11):e2243597. doi: 10.1001/jamanetworkopen.2022.43597. JAMA Netw Open. 2022. PMID: 36416824 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

133 results

Results by year